Chai, X.-N.; Ludwig, F.-A.; Müglitz, A.; Schaefer, M.; Yin, H.-Y.; Brust, P.; Regenthal, R.; Krügel, U.
Validation of an LC-MS/MS Method to Quantify the New TRPC6 Inhibitor SH045 (Larixyl N-methylcarbamate) and Its Application in an Exploratory Pharmacokinetic Study in Mice. Pharmaceuticals 2021, 14, 259.
https://doi.org/10.3390/ph14030259
AMA Style
Chai X-N, Ludwig F-A, Müglitz A, Schaefer M, Yin H-Y, Brust P, Regenthal R, Krügel U.
Validation of an LC-MS/MS Method to Quantify the New TRPC6 Inhibitor SH045 (Larixyl N-methylcarbamate) and Its Application in an Exploratory Pharmacokinetic Study in Mice. Pharmaceuticals. 2021; 14(3):259.
https://doi.org/10.3390/ph14030259
Chicago/Turabian Style
Chai, Xiao-Ning, Friedrich-Alexander Ludwig, Anne Müglitz, Michael Schaefer, Hai-Yan Yin, Peter Brust, Ralf Regenthal, and Ute Krügel.
2021. "Validation of an LC-MS/MS Method to Quantify the New TRPC6 Inhibitor SH045 (Larixyl N-methylcarbamate) and Its Application in an Exploratory Pharmacokinetic Study in Mice" Pharmaceuticals 14, no. 3: 259.
https://doi.org/10.3390/ph14030259
APA Style
Chai, X.-N., Ludwig, F.-A., Müglitz, A., Schaefer, M., Yin, H.-Y., Brust, P., Regenthal, R., & Krügel, U.
(2021). Validation of an LC-MS/MS Method to Quantify the New TRPC6 Inhibitor SH045 (Larixyl N-methylcarbamate) and Its Application in an Exploratory Pharmacokinetic Study in Mice. Pharmaceuticals, 14(3), 259.
https://doi.org/10.3390/ph14030259
